Form 4 for AORT ARTIVION, INC.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0000784199-22-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-11 | 2022-02-09+ | AORT | Mackin James P | Pres, CEO | S - Sale+OE | $18.00 | -21.3K | 304.2K | -7% | -$383.0K |
| DM | 2022-02-11 | 2022-02-09+ | AORT | Mackin James P | Pres, CEO | M - OptEx | $11.00 | +21.3K | 314.8K | +7% | +$234.0K |
| DM | 2022-02-11 | 2022-02-09+ | AORT | Mackin James P | Pres, CEO | M - OptEx | $11.00 | -21.3K | 0 | -100% | -$234.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | S | D | 10,638 | $18.14 | 304,178 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 (F2) Reflects weighted average price. Range of prices were between $17.93 to $18.36. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-02-09 | M | A | 10,638 | $11.00 | 314,816 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 |
| 3 | Common | Common Stock | 2022-02-10 | M | A | 10,639 | $11.00 | 314,817 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 |
| 4 | Common | Common Stock | 2022-02-10 | S | D | 10,639 | $17.86 | 304,178 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 (F3) Reflects weighted average price. Range of prices were between $17.69 to $18.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | StockOption(RightToBuy) | 2022-02-09 | M | D | 10,638 | $11.00 | 10,639 | D | $11.00 · 2016-02-19 to 2022-02-19 | 10,638 Common Stock | (F4) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 |
| 6 | Derivative | StockOption(RightToBuy) | 2022-02-10 | M | D | 10,639 | $11.00 | 0 | D | $11.00 · 2016-02-19 to 2022-02-19 | 10,639 Common Stock | (F4) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 |